logo

FDA Calendar

Share
Company Name Supernus Pharmaceuticals, Inc.
Drug Name SPN-812 (NDA)
Event Name FDA decision on SPN-812 for the treatment of ADHD
Event Date 11/08/2020
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar